Flecainide Acetate Tablet
Product Images NDC 65862-621

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Flecainide Acetate (NDC 65862-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg (30 Tablets Bottle))

Flecainide Acetate Tablets, USP 50 mg label from Aurobindo Pharma Limited. The label states the product is Rx only, contains 30 tablets, and each tablet contains 50 mg Flecainide acetate USP. It includes storage instructions and distributor information for Aurobindo Pharma USA, Inc., with a barcode on the right side. The label also shows a designated overprinting and coding area for batch information.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablets Bottle))

Label for Flecainide Acetate Tablets USP 100 mg, containing 30 tablets. Distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, pharmacist dispensing notes, dosage reference, and NDC 65862-622-30. It specifies the product is made in India and is for prescription use only.*

FDA Label Image

Package Label-principal Display Panel (150 mg (30 Tablets Bottle))

Label for Flecainide Acetate Tablets USP 150 mg by Aurobindo Pharma Limited. The label shows a 30 tablet bulk package with dosage instructions referencing the package insert. It includes storage guidance at 20° to 25°C and states it is for prescription use only. The label also features a barcode, product codes, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Flecainide Str)

Chemical structure of Flecainide Acetate showing its molecular components and arrangement, including trifluoromethoxy and piperidine groups as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.